<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bendok BR</submitter><funding>NCATS NIH HHS</funding><funding>Northwestern University</funding><funding>Mayo Clinic</funding><pagination>615-624</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7534546</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>86(5)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Aneurysm recurrence after coiling has been associated with aneurysm growth, (re)hemorrhage, and a greater need for follow-up. The second-generation HydroCoil Embolic System (HES; MicroVention, Inc) consists of a platinum core with integrated hydrogel and was developed to reduce recurrence through enhancing packing density and healing within the aneurysm.&lt;h4>Objective&lt;/h4>To compare recurrence between the second-generation HES and bare platinum coil (BPC) in the new-generation Hydrogel Endovascular Aneurysm Treatment Trial (HEAT).&lt;h4>Methods&lt;/h4>HEAT is a randomized, controlled trial that enrolled subjects with ruptured or unruptured 3- to 14-mm intracranial aneurysms amenable to coiling. The primary endpoint was aneurysm recurrence using the Raymond-Roy scale. Secondary </pubmed_abstract><journal>Neurosurgery</journal><pubmed_title>The Hydrogel Endovascular Aneurysm Treatment Trial (HEAT): A Randomized Controlled Trial of the Second-Generation Hydrogel Coil.</pubmed_title><pmcid>PMC7534546</pmcid><funding_grant_id>UL1 TR001422</funding_grant_id><pubmed_authors>Bendok BR</pubmed_authors><pubmed_authors>Patra DP</pubmed_authors><pubmed_authors>van Adel B</pubmed_authors><pubmed_authors>Ward JD</pubmed_authors><pubmed_authors>Wang D</pubmed_authors><pubmed_authors>Tummala R</pubmed_authors><pubmed_authors>Woo HH</pubmed_authors><pubmed_authors>Dashti SR</pubmed_authors><pubmed_authors>Jindal G</pubmed_authors><pubmed_authors>Carpenter J</pubmed_authors><pubmed_authors>Abi-Aad KR</pubmed_authors><pubmed_authors>El Ahmadieh TY</pubmed_authors><pubmed_authors>Delgado J</pubmed_authors><pubmed_authors>James R</pubmed_authors><pubmed_authors>Delgado Almandoz JE</pubmed_authors><pubmed_authors>Grobelny T</pubmed_authors><pubmed_authors>Aoun RJN</pubmed_authors><pubmed_authors>Hussain M</pubmed_authors><pubmed_authors>Moran C</pubmed_authors><pubmed_authors>Deshaies E</pubmed_authors><pubmed_authors>Evans A</pubmed_authors><pubmed_authors>Luh G</pubmed_authors><pubmed_authors>Dashti S</pubmed_authors><pubmed_authors>Patsalides A</pubmed_authors><pubmed_authors>Garg A</pubmed_authors><pubmed_authors>Bozorgchami H</pubmed_authors><pubmed_authors>Sauvageau E</pubmed_authors><pubmed_authors>Aoun SG</pubmed_authors><pubmed_authors>Zammar SG</pubmed_authors><pubmed_authors>Veznedaroglu E</pubmed_authors><pubmed_authors>El Tecle NE</pubmed_authors><pubmed_authors>Scott JA</pubmed_authors><pubmed_authors>Fields J</pubmed_authors><pubmed_authors>Hirsch J</pubmed_authors><pubmed_authors>Lee S</pubmed_authors><pubmed_authors>Chaudry I</pubmed_authors><pubmed_authors>Shankar J</pubmed_authors><pubmed_authors>Fiorella D</pubmed_authors><pubmed_authors>HEAT Study Investigators</pubmed_authors><pubmed_authors>Jabbour P</pubmed_authors><pubmed_authors>Kanaan H</pubmed_authors><pubmed_authors>Raymond J</pubmed_authors><pubmed_authors>Klucznik R</pubmed_authors><pubmed_authors>Ansari SA</pubmed_authors><pubmed_authors>Powers C</pubmed_authors><pubmed_authors>Pandey A</pubmed_authors><pubmed_authors>Kelly M</pubmed_authors><pubmed_authors>Lavine S</pubmed_authors><pubmed_authors>Kwasny MJ</pubmed_authors><pubmed_authors>Dabus G</pubmed_authors><pubmed_authors>Rahme RJ</pubmed_authors><pubmed_authors>Ansari S</pubmed_authors><pubmed_authors>Albuquerque F</pubmed_authors><pubmed_authors>Kalmes D</pubmed_authors><pubmed_authors>Boulos A</pubmed_authors><pubmed_authors>Satti S</pubmed_authors><pubmed_authors>Romero C</pubmed_authors><pubmed_authors>Kniss JF</pubmed_authors><pubmed_authors>Jayaraman M</pubmed_authors><pubmed_authors>Milot G</pubmed_authors><pubmed_authors>Cortes M</pubmed_authors><pubmed_authors>DeNardo AJ</pubmed_authors><pubmed_authors>Tawk R</pubmed_authors><pubmed_authors>Xavier A</pubmed_authors><pubmed_authors>Hartman J</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Hydrogel Endovascular Aneurysm Treatment Trial (HEAT): A Randomized Controlled Trial of the Second-Generation Hydrogel Coil.</name><description>&lt;h4>Background&lt;/h4>Aneurysm recurrence after coiling has been associated with aneurysm growth, (re)hemorrhage, and a greater need for follow-up. The second-generation HydroCoil Embolic System (HES; MicroVention, Inc) consists of a platinum core with integrated hydrogel and was developed to reduce recurrence through enhancing packing density and healing within the aneurysm.&lt;h4>Objective&lt;/h4>To compare recurrence between the second-generation HES and bare platinum coil (BPC) in the new-generation Hydrogel Endovascular Aneurysm Treatment Trial (HEAT).&lt;h4>Methods&lt;/h4>HEAT is a randomized, controlled trial that enrolled subjects with ruptured or unruptured 3- to 14-mm intracranial aneurysms amenable to coiling. The primary endpoint was aneurysm recurrence using the Raymond-Roy scale. Secondary </description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 May</publication><modification>2026-04-08T02:27:39.137Z</modification><creation>2020-10-29T09:07:40Z</creation></dates><accession>S-EPMC7534546</accession><cross_references><pubmed>32078692</pubmed><doi>10.1093/neuros/nyaa006</doi></cross_references></HashMap>